...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics

Buckeyes, while the wheels of progress with RVX do move agonizingly slowly I do think we will get our partner news soon enough.  I can't see this dragging out much more than the next 2-3 months without the catchphrase of 'ongoing discussions' losing all credibility, and they must be aware of that.  This must be what is fueling the talk of an increased pps, and who knows what can happen there.  But when they do announce a partner, and the path forward, it wouldn't also surprise me to learn that, as part of that arrangement, DM will in all likelihood step down as CEO and pass the torch to someone else.  It will be a fascinating few months ahead ......for many reasons.  Life never ceases to entertain.

Share
New Message
Please login to post a reply